Study of Origin,Sample ID,Cancer Type,Cancer Type Detailed,Protein Change,Annotation OncoKB,Functional Impact Mutation Assesor,Score Mutation Assesor,Functional Impact SIFT,Score SIFT,Functional Impact Polyphen-2,Score Polyphen-2,Copy #,COSMIC,MS,VS,Center,Chromosome,Start Pos,End Pos,Ref,Var,HGVSg,HGVSc,Allele Freq (T),Allele Freq (N),Variant Reads,Ref Reads,Variant Reads (Normal),Ref Reads (Normal),# Mut in Sample,Exon,gnomAD,ClinVar,dbSNP,SIGNAL,Age at Which Sequencing was Reported (Years),Patient Current Age,Archer Panel,Ethnicity Category,Fraction Genome Altered,Gene Panel,Institute Source,Metastatic Site,MSI Comment,MSI Score,MSI Type,Oncotree Code,Overall Survival (Months),Overall Survival Status,Pediatric Case Indicator,Primary Tumor Site,Race Category,Religion,Sample Class,Number of Samples Per Patient,Sample coverage,Sample Type,Sex,Somatic Status,TMB (nonsynonymous),Tumor Purity,Consensus HR Status,Consensus Signature,Gyn Diagnosis Chemo Intent Description,Gyn Diagnosis Histology,MSK Slide ID,Myriad GIS Score,Myriad Signature,Path Slide Exists,Patient Age At Diagnosis,Patient Display Name,Patient Isabl ID,Procedure,Procedure Type,Therapy,Tumor Megasite,Tumor Site,Tumor Subsite,Tumor Supersite,WGS Signature,Diagnosis Age,Neoplasm Disease Stage American Joint Committee on Cancer Code,American Joint Committee on Cancer Publication Version Type,Neoplasm American Joint Committee on Cancer Clinical Group Stage,Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage,Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage,Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage,Days to Sample Collection.,Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value,days_to_patient_progression_free,Days to Sample Procurement,days_to_tumor_progression,Disease Free (Months),Disease Free Status,Disease code,Performance Status,Lymphomatous Extranodal Site Involvement Indicator,Form completion date,Neoplasm Histologic Grade,Neoplasm Histologic Type Name,Neoadjuvant Therapy Type Administered Prior To Resection Text,Prior Cancer Diagnosis Occurence,ICD-10 Classification,"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code",Informed consent verified,Year Cancer Initial Diagnosis,Is FFPE,Patient Jewish Heritage Text Category,Karnofsky Performance Score,Longest Dimension,Lymphovascular invasion indicator,First Pathologic Diagnosis Biospecimen Acquisition Method Type,First Pathologic Diagnosis Biospecimen Acquisition Other Method Type,First Pathologic Diagnosis Biospecimen Acquisition Method Type,New Neoplasm Event Post Initial Therapy Indicator,Oct embedded,Specimen Collection Method,Other Patient ID,Other Sample ID,Pathology Report File Name,Pathology report uuid,American Joint Committee on Cancer Metastasis Stage Code,Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code,American Joint Committee on Cancer Tumor Stage Code,Performance Status Assessment Timepoint Category,Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator,Project code,Tissue Prospective Collection Indicator,Did patient start adjuvant postoperative radiotherapy?,Surgical Margin Resection Status,Tissue Retrospective Collection Indicator,Sample Initial Weight,Sample type id,Shortest Dimension,Specimen Current Weight,Specimen Freezing Means,Specimen Second Longest Dimension,Stage Other,Time between clamping and freezing,Time between excision and freezing,Tissue Source Site,Primary Therapy Outcome Success Type,Person Neoplasm Status,Tumor Disease Anatomic Site,Vascular invasion indicator,Vial number,Aneuploidy Score,Buffa Hypoxia Score,TCGA PanCanAtlas Cancer Type Acronym,Last Communication Contact from Initial Pathologic Diagnosis Date,Birth from Initial Pathologic Diagnosis Date,Months of disease-specific survival,Disease-specific Survival status,Genetic Ancestry Label,In PanCan Pathway Analysis,MSI MANTIS Score,MSIsensor Score,Person Neoplasm Cancer Status,Progress Free Survival (Months),Progression Free Status,Primary Lymph Node Presentation Assessment,Prior Diagnosis,Radiation Therapy,Ragnum Hypoxia Score,Subtype,Tissue Prospective Collection Indicator,Tissue Retrospective Collection Indicator,Tissue Source Site Code,Tumor Type,Patient Weight,Winter Hypoxia Score,ACGH Data,Complete Data,MRNA Data,Platinum Status,Primary Therapy Outcome Success,Sequenced,Tumor Residual Disease,Tumor Stage 2009,Year of Diagnosis
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-1489-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,N1265Kfs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,genome.wustl.edu,17,41243753,41243754,-,TT,17:g.41243753_41243754insTT,ENST00000357654.3:c.3793_3794dup,,,,,,,45,oct-23,,,,,,,,,8.985,,,,,,,HGSOC,82.82,0:LIVING,,,,,,1,,Primary,,Matched,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.48,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-04-1357-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1538*,Likely Oncogenic,NA,, NA,,NA,,Diploid,1,Somatic,Valid,broad.mit.edu,17,41226411,41226411,G,A,17:g.41226411G>A,ENST00000357654.3:c.4612C>T,,,,,,,53,14/23,,Pathogenic,,,,,,,4.413,,,,,,,HGSOC,,0:LIVING,,,,,,1,,Primary,,Matched,1.766.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,,Yes,,IIIB,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-29-2427-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,L431*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,broad.mit.edu,17,41246256,41246256,A,C,17:g.41246256A>C,ENST00000357654.3:c.1292T>G,,,,,,,48,oct-23,,Pathogenic,,,,,,,3.124,,,,,,,HGSOC,62.42,0:LIVING,,,,,,1,,Primary,,Matched,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51.94,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-25-1630-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,A521Qfs*11,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,hgsc.bcm.edu,17,41245991,41245991,C,-,17:g.41245991del,ENST00000357654.3:c.1557del,,,,,,,35,oct-23,,,,,,,,,3.297,,,,,,,HGSOC,38.18,1:DECEASED,,,,,,1,,Primary,,Matched,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0730-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R1835*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,2,Somatic,Valid,hgsc.bcm.edu,17,41197784,41197784,G,A,17:g.41197784G>A,ENST00000357654.3:c.5503C>T,,,,,,,29,23/23,,Pathogenic,,17,,,,,6.489,,,,,,,HGSOC,17.77,1:DECEASED,,,,,,1,,Primary,,Matched,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0804-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,C47W,Likely Oncogenic,high,4.23, NA,,NA,,ShallowDel,2,Somatic,Valid,genome.wustl.edu,17,41258544,41258544,G,C,17:g.41258544G>C,ENST00000357654.3:c.141C>G,,,,,,,29,abr-23,,not_provided,,,,,,,4.749,,,,,,,HGSOC,35.25,1:DECEASED,,,,,,1,,Primary,,Matched,966.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.81,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Resistant,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-24-2035-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,G1710Efs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,broad.mit.edu,17,41215914,41215914,C,-,17:g.41215914del,ENST00000357654.3:c.5129del,,,,,,,69,17/23,,Pathogenic,,,,,,,3.251,,,,,,,HGSOC,28.16,1:DECEASED,,,,,,1,,Primary,,Matched,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.43,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Partial Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-25-1632-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,S1217Rfs*21,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,NA,hgsc.bcm.edu,17,41243899,41243900,-,TAAGTTCT,17:g.41243899_41243900insTAAGTTCT,ENST00000357654.3:c.3641_3648dup,,,,,,,37,oct-23,,,,,,,,,5.371,,,,,,,HGSOC,59.1,1:DECEASED,,,,,,1,,Primary,,Matched,1.233.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17.64,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,1-10 mm,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-1026-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,G813Dfs*2,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,hgsc.bcm.edu,17,41245110,41245110,C,-,17:g.41245110del,ENST00000357654.3:c.2438del,,,,,,,26,oct-23,,,,,,,,,2.905,,,,,,,HGSOC,26.81,0:LIVING,,,,,,1,,Primary,,Matched,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.18,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-25-1625-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E116*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,hgsc.bcm.edu,17,41256234,41256234,C,A,17:g.41256234C>A,ENST00000357654.3:c.346G>T,,,,,,,31,jun-23,,Pathogenic,,,,,,,0.4,,,,,,,HGSOC,27.6,1:DECEASED,,,,,,1,,Primary,,Matched,1.033.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17.28,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Stable Disease,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0761-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,X1495_splice,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Somatic,Valid,hgsc.bcm.edu,17,41228504,41228504,C,-,17:g.41228504del,ENST00000357654.3:c.4484+1del,,,,,,,46,,,Pathogenic,,,,,,,4.004,,,,,,,HGSOC,34.04,0:LIVING,,,,,,1,,Primary,,Matched,1.566.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13.9,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,No Macroscopic disease,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-13-1489-01,Ovarian Cancer,Serous Ovarian Cancer,N1265Kfs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Valid,genome.wustl.edu,17,41243753,41243754,-,TT,17:g.41243753_41243754insTT,ENST00000357654.3:c.3793_3794dup,,,,,,,45,oct-23,,,,,,,,NOT HISPANIC OR LATINO,8.985,,,,,,,SOC,83.87,1:DECEASED,,Bilateral,WHITE,,,2,,Primary,Female,Matched,1.533.333.333,,,,,,,,,,,,,,,,,,,,,70,,,Stage IIIC,,,,,0,,,,26.48,1:Recurred/Progressed,,,,3/31/09,G2,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2002,NO,,80,1.7,,Tumor resection,,,,,,7248cd60-be22-44bc-bc58-f644db0940a2,4b2b6e5e-248c-46f6-938a-95571577e02d,TCGA-13-1489.C65BE57D-0015-49BB-A4BE-81D7B302F464.pdf,C65BE57D-0015-49BB-A4BE-81D7B302F464,,,,Pre-Adjuvant Therapy,,,,,,,,1,0.4,,,1,,,,13,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-04-1357-01,Ovarian Cancer,Serous Ovarian Cancer,Q1538*,Likely Oncogenic,NA,, NA,,NA,,Diploid,1,Unknown,Unknown,broad.mit.edu,17,41226411,41226411,G,A,17:g.41226411G>A,ENST00000357654.3:c.4612C>T,,,,,,,53,14/23,,Pathogenic,,,,,,,4.413,,,,,,,SOC,,0:LIVING,,,,,,1,,Primary,Female,Matched,1.8,,,,,,,,,,,,,,,,,,,,,52,,,Stage IIIB,,,,,0,,,,,0:DiseaseFree,,,,3/26/09,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2005,NO,,,1.5,,,,,,,,feda41d8-ca56-425d-b149-4d5485328107,45893b0e-301f-474a-b390-936d7d74f57e,TCGA-04-1357.D1D902A3-DF76-4623-B2E7-88FFA9E1542F.pdf,D1D902A3-DF76-4623-B2E7-88FFA9E1542F,,,,,,,,,,,,1,0.6,,,0.6,,,,4,,,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-29-2427-01,Ovarian Cancer,Serous Ovarian Cancer,L431*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Unknown,Unknown,broad.mit.edu,17,41246256,41246256,A,C,17:g.41246256A>C,ENST00000357654.3:c.1292T>G,,,,,,,49,oct-23,,Pathogenic,,,,,,,3.124,,,,,,,SOC,62.42,0:LIVING,,Left,WHITE,,,1,,Primary,Female,Matched,1.633.333.333,,,,,,,,,,,,,,,,,,,,,60,,,Stage IIIC,,,,,0,,,,51.97,1:Recurred/Progressed,,0,,02/08/2010,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2004,NO,,,1.5,,Tumor resection,,,,,,6f25001a-f890-4fd0-a994-e62a9ea5c6f3,41b8564a-48df-44ab-9242-8d1d89697658,TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf,b53536ca-770c-4482-b2f7-4284d804db2e,,,,Post-Adjuvant Therapy,,,,,R1,,,1,0.5,,,1,,,,29,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-25-1630-01,Ovarian Cancer,Serous Ovarian Cancer,A521Qfs*11,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Unknown,hgsc.bcm.edu,17,41245991,41245991,C,-,17:g.41245991del,ENST00000357654.3:c.1557del,,,,,,,36,oct-23,,,,,,,,NOT HISPANIC OR LATINO,3.297,,,,,,,SOC,38.17,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,1.2,,,,,,,,,,,,,,,,,,,,,73,,,Stage IIIC,,,,,0,,,,,,,,,06/02/2009,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2002,NO,,,1.4,,Tumor resection,,,,,,263e85e2-7b6f-453f-8fd0-e5ea1409fece,899b4fa3-95cb-4f8e-930c-bc29e20b5144,TCGA-25-1630.0BF406EC-B97B-4A05-9EBB-F40CF96233E9.pdf,0BF406EC-B97B-4A05-9EBB-F40CF96233E9,,,,,,,,,,,,1,0.4,,,1,,,,25,,,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-13-0730-01,Ovarian Cancer,Serous Ovarian Cancer,R1835*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,2,Somatic,Valid,hgsc.bcm.edu,17,41197784,41197784,G,A,17:g.41197784G>A,ENST00000357654.3:c.5503C>T,,,,,,,30,23/23,,Pathogenic,,17,,,,NOT HISPANIC OR LATINO,6.489,,,,,,,SOC,17.81,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,1,,,,,,,,,,,,,,,,,,,,,71,,,Stage IIIC,,,,,0,,,,,,,,,2/24/09,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2003,NO,,,1.1,,Fine needle aspiration biopsy,,,,,,2ebb738c-4829-4720-931a-96c0fd117e2a,bbe4ea81-6f31-4589-8797-b140bcb35d2b,TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf,2AF2844E-F1DC-4938-85D3-08B07BB9DCFF,,,,,,,,,,,,1,0.4,,,0.6,,,,13,,,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-13-0804-01,Ovarian Cancer,Serous Ovarian Cancer,C47W,Likely Oncogenic,high,4.23, NA,,NA,,ShallowDel,2,Somatic,Valid,genome.wustl.edu,17,41258544,41258544,G,C,17:g.41258544G>C,ENST00000357654.3:c.141C>G,,,,,,,29,abr-23,,not_provided,,,,,,NOT HISPANIC OR LATINO,4.749,,,,,,,SOC,35.25,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,966.666.667,,,,,,,,,,,,,,,,,,,,,73,,,Stage IIIC,,,,,0,,,,10.81,1:Recurred/Progressed,,,,2/25/09,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2003,NO,,,1.5,,Cytology (e.g. Peritoneal or pleural fluid),,,,,,7e34d3c1-1fab-4326-9a69-4260d2bac558,7432f954-a16f-4053-bedd-aa776f939f71,TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf,34870541-DEE9-4B39-A292-117E443B1CBF,,,,,,,,,,,,1,0.3,,,1.3,,,,13,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-24-2035-01,Ovarian Cancer,Serous Ovarian Cancer,G1710Efs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Unknown,Unknown,broad.mit.edu,17,41215914,41215914,C,-,17:g.41215914del,ENST00000357654.3:c.5129del,,,,,,,84,17/23,,Pathogenic,,,,,,,3.251,,,,,,,SOC,28.15,1:DECEASED,,Left,WHITE,,,1,,Primary,Female,Matched,2.8,,,,,,,,,,,,,,,,,,,,,65,,,Stage IIIC,,,,,0,,,,9.43,1:Recurred/Progressed,,0,,3/29/10,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,1996,NO,,,1,,Tumor resection,,,,,,062982f8-9f49-425a-99e9-008af5ed9040,e4ccc95d-79ca-49e3-8cd0-c8452c5f9aa2,TCGA-24-2035.025d4b31-5832-451a-9f70-e0281f698aa6.pdf,025d4b31-5832-451a-9f70-e0281f698aa6,,,,Post-Adjuvant Therapy,,,,,,,,1,0.3,,,0.7,,,,24,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-25-1632-01,Ovarian Cancer,Serous Ovarian Cancer,S1217Rfs*21,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Unknown,hgsc.bcm.edu,17,41243899,41243900,-,TAAGTTCT,17:g.41243899_41243900insTAAGTTCT,ENST00000357654.3:c.3641_3648dup,,,,,,,48,oct-23,,,,,,,,NOT HISPANIC OR LATINO,5.371,,,,,,,SOC,59.1,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,1.6,,,,,,,,,,,,,,,,,,,,,68,,,Stage IV,,,,,0,,,,17.64,1:Recurred/Progressed,,,,06/02/2009,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2002,NO,,,1.4,,Tumor resection,,,,,,c435627c-159d-4a6d-a819-30abac24bf4d,ed9c97d8-4df2-4ed3-b455-4955d72901a8,TCGA-25-1632.F083C2B4-20DE-440F-B6A8-2F332346CECA.pdf,F083C2B4-20DE-440F-B6A8-2F332346CECA,,,,,,,,,,,,1,0.3,,,0.8,,,,25,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-23-1026-01,Ovarian Cancer,Serous Ovarian Cancer,G813Dfs*2,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Unknown,hgsc.bcm.edu,17,41245110,41245110,C,-,17:g.41245110del,ENST00000357654.3:c.2438del,,,,,,,23,oct-23,,,,,,,,NOT HISPANIC OR LATINO,2.905,,,,,,,SOC,26.81,0:LIVING,,Left,WHITE,,,1,,Primary,Female,Matched,766.666.667,,,,,,,,,,,,,,,,,,,,,45,,,Stage IIIC,,,,,0,,,,26.18,1:Recurred/Progressed,,,,2/23/09,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2004,NO,,,0.8,,Tumor resection,,,,,,c6ede8ae-881c-47a0-a0ef-745ed4b7764a,30d07f1e-0899-4d8f-9bd9-abe572affc8c,TCGA-23-1026.E41E1018-422B-4B4A-8732-C9389847830D.pdf,E41E1018-422B-4B4A-8732-C9389847830D,,,,,,,,,,,,1,0.4,,,0.7,,,,23,,WITH TUMOR,Ovary,,B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-25-1625-01,Ovarian Cancer,Serous Ovarian Cancer,E116*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,Somatic,Unknown,hgsc.bcm.edu,17,41256234,41256234,C,A,17:g.41256234C>A,ENST00000357654.3:c.346G>T,,,,,,,31,jun-23,,Pathogenic,,,,,,NOT HISPANIC OR LATINO,0.4,,,,,,,SOC,27.6,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,1.033.333.333,,,,,,,,,,,,,,,,,,,,,66,,,Stage IIIC,,,,,0,,,,17.28,1:Recurred/Progressed,,,,06/02/2009,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2006,NO,,,1.5,,Tumor resection,,,,,,88d61634-913c-435a-8d25-e019c8dab7da,4ee39504-ac69-4dd7-b8a4-8d1cc3c20418,TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf,BDE314E3-1E2C-440E-8561-A260C1D0933A,,,,,,,,,,,,1,0.3,,,1.3,,,,25,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"High-Grade Serous Ovarian Cancer (MSK, NPJ Genome Med 2021)",P-0021359-T01-IM6,Ovarian Cancer,High-Grade Serous Ovarian Cancer,X1803_splice,Likely Oncogenic,NA,, NA,,NA,,Diploid,,SOMATIC,Unknown,MSKCC,17,41199721,41199721,C,G,17:g.41199721C>G,ENST00000357654.3:c.5407-1G>C,0.07,,57,812,,615,7,,,Pathogenic/Likely_pathogenic,,,60,61,NO,Non-Spanish; Non-Hispanic,801,IMPACT468,MSKCC,Soft Tissue,MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.,0,Stable,HGSOC,17.688,1:DECEASED,No,Ovary,WHITE,CHRISTIAN,Tumor,1,779,Metastasis,Female,Matched,6.052.886.665,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-13-1489-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,N1265Kfs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41243753,41243754,-,TT,17:g.41243753_41243754insTT,ENST00000357654.3:c.3793_3794dup,0.55,,251,203,,604,58,oct-23,,,,,,,,Not Hispanic Or Latino,8.985,,,,,,,SOC,8.393.332.676,1:DECEASED,,,White,,,1,,Primary,Female,Matched,1.966.666.667,,,,,,,,,,,,,,,,,,,,,70,,,,,,,,0,,,,2.649.833.974,1:Recurred/Progressed,,,,3/31/09,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,Yes,,,7248cd60-be22-44bc-bc58-f644db0940a2,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,19,37,OV,2521,-25768,8.393.332.676,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,3.082,2.7,With Tumor,2.649.833.974,1:PROGRESSION,,,No,12,OV,,,13,Serous Cystadenocarcinoma,,34,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-04-1357-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,Q1538*,Likely Oncogenic,NA,, NA,,NA,,Diploid,1,.,.,.,17,41226411,41226411,G,A,17:g.41226411G>A,ENST00000357654.3:c.4612C>T,0.61,,415,270,,598,86,14/23,,Pathogenic,,,,,,,4.413,,,,,,,SOC,,0:LIVING,,,,,,1,,Primary,Female,Matched,2.866.666.667,,,,,,,,,,,,,,,,,,,,,52,,,,,,,,0,,,,,,,,,3/26/09,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,feda41d8-ca56-425d-b149-4d5485328107,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,12,-13,OV,,-18999,,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.937,0.17,,,0:CENSORED,,,No,-12,OV,,,4,Serous Cystadenocarcinoma,,-34,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-29-2427-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,L431*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41246256,41246256,A,C,17:g.41246256A>C,ENST00000357654.3:c.1292T>G,0.56,,63,50,,169,69,oct-23,,Pathogenic,,,,,,,3.124,,,,,,,SOC,6.246.506.888,0:LIVING,,,White,,,1,,Primary,Female,Matched,2.3,,,,,,,,,,,,,,,,,,,,,60,,,,,,,,0,,,,5.201.038.893,1:Recurred/Progressed,,,,02/08/2010,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,6f25001a-f890-4fd0-a994-e62a9ea5c6f3,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,10,5,OV,1900,-21940,6.246.506.888,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.676,0.2,With Tumor,5.201.038.893,1:PROGRESSION,,,No,6,OV,,,29,Serous Cystadenocarcinoma,,-14,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-09-2043-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,W1718*,Likely Oncogenic,NA,, NA,,NA,,Diploid,,.,.,.,17,41215390,41215390,C,T,17:g.41215390C>T,ENST00000357654.3:c.5153G>A,0.8,,77,19,,103,105,18/23,,Pathogenic,,,,,,Not Hispanic Or Latino,5.683,,,,,,,SOC,6.180.754.184,0:LIVING,,,White,,,1,,Primary,Female,Matched,3.5,,,,,,,,,,,,,,,,,,,,,69,,,,,,,,0,,,,6.180.754.184,0:DiseaseFree,,,,11/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,2e05cd3a-a55f-43b8-b2a9-72fb742b89c9,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,9,,OV,188,-25480,6.180.754.184,0:ALIVE OR DEAD TUMOR FREE,EUR,No,3.258,1.38,Tumor Free,6.180.754.184,0:CENSORED,,,No,,,,,9,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-20-1682-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,Y655Vfs*18,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,2,.,.,.,17,41245586,41245587,-,T,17:g.41245586_41245587insT,ENST00000357654.3:c.1961dup,0.54,,95,82,,256,88,oct-23,,Pathogenic,,,,,,Not Hispanic Or Latino,8.104,,,,,,,SOC,2.751.750.666,0:LIVING,,,White,,,1,,Primary,Female,Matched,2.9,,,,,,,,,,,,,,,,,,,,,56,,,,,,,,0,,,,2.751.750.666,0:DiseaseFree,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,94bd4c68-4bfc-4db3-9365-97c867747133,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,10,23,OV,837,-20583,2.751.750.666,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.609,1.58,Tumor Free,2.751.750.666,0:CENSORED,,,No,22,OV,,,20,Serous Cystadenocarcinoma,,18,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-24-1847-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,E111*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41256249,41256249,C,A,17:g.41256249C>A,ENST00000357654.3:c.331G>T,0.52,,60,55,,178,93,jun-23,,Pathogenic,,,,,,,6.355,,,,,,,SOC,1.127.658.875,0:LIVING,,,White,,,1,,Primary,Female,Matched,3.1,,,,,,,,,,,,,,,,,,,,,45,,,,,,,,0,,,,,,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,21966708-4e66-4211-add0-f1515b09e362,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,13,23,OV,343,-16529,1.127.658.875,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.643,0.53,Tumor Free,1.127.658.875,0:CENSORED,,,No,10,OV,,,24,Serous Cystadenocarcinoma,,22,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-36-2534-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,X1760_splice,Likely Oncogenic,NA,, NA,,NA,,Diploid,,.,.,.,17,41203135,41203135,C,A,17:g.41203135C>A,ENST00000357654.3:c.5278-1G>T,0.91,,367,35,,347,126,,,Pathogenic,,,,,,,4.717,,,,,,,SOC,298.188.513,0:LIVING,,,White,,,1,,Primary,Female,Matched,4.233.333.333,,,,,,,,,,,,,,,,,,,,,72,,,,,,,,0,,,,,,,,,8/18/10,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,e08a619d-8a55-435d-8c41-a77a112ed889,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,4,,OV,907,-26621,298.188.513,0:ALIVE OR DEAD TUMOR FREE,EUR,No,2.821,1.71,With Tumor,1.259.164.283,1:PROGRESSION,,,No,,,,,36,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-42-2591-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,M1?,Likely Oncogenic,impact:,undefined, NA,,NA,,Diploid,1,.,.,.,17,41276113,41276113,T,C,17:g.41276113T>C,ENST00000357654.3:c.1A>G,0.93,,148,11,,201,63,feb-23,,Pathogenic,,,,,,Not Hispanic Or Latino,9.339,,,,,,,SOC,4.076.667.653,0:LIVING,,,White,,,1,,Primary,Female,Matched,2.1,,,,,,,,,,,,,,,,,,,,,51,,,,,,,,0,,,,4.076.667.653,0:DiseaseFree,,,,06/03/2010,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,No,,,0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,7,,OV,1240,-18654,4.076.667.653,0:ALIVE OR DEAD TUMOR FREE,EUR,No,2.927,1.98,Tumor Free,4.076.667.653,0:CENSORED,,,No,,,,,42,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-61-2096-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,W1837L,Likely Oncogenic,medium,2.33, deleterious,0,probably_damaging,1,ShallowDel,,.,.,.,17,41197777,41197777,C,A,17:g.41197777C>A,ENST00000357654.3:c.5510G>T,0.78,,49,14,,120,116,23/23,,not_provided,,,,,,,3.766,,,,,,,SOC,5.838.840.122,0:LIVING,,,White,,,1,,Primary,Female,Matched,3.9,,,,,,,,,,,,,,,,,,,,,56,,,,,,,,0,,,,,,,,,12/07/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,6beaa1cb-a9f1-4127-898c-7aff2273788e,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,7,,OV,1776,-20663,5.838.840.122,0:ALIVE OR DEAD TUMOR FREE,EUR,No,2.971,1.17,Tumor Free,1.384.094.421,1:PROGRESSION,,,No,,,,,61,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-04-1335-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,I1108*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,.,.,.,17,41244226,41244226,T,-,17:g.41244226del,ENST00000357654.3:c.3322del,0.33,,39,81,,82,15,oct-23,,,,,,,,Not Hispanic Or Latino,3.906,,,,,,,SOC,1.808.199.362,1:DECEASED,,,Black or African American,,,1,,Primary,Female,Matched,0.5,,,,,,,,,,,,,,,,,,,,,60,,,,,,,,0,,,,,,,,,3/26/09,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,ab3dbbbe-eed6-4a35-a505-1815225e86c9,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,6,,OV,55,-21963,1.808.199.362,1:DEAD WITH TUMOR,AFR,No,,14.65,With Tumor,1.808.199.362,1:PROGRESSION,,,No,,,,,4,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-23-2641-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,D749Vfs*4,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,.,.,.,17,41245302,41245302,T,-,17:g.41245302del,ENST00000357654.3:c.2246del,0.47,,110,126,,235,82,oct-23,,,,,,,,Not Hispanic Or Latino,8.725,,,,,,,SOC,2.761.613.571,0:LIVING,,,White,,,1,,Primary,Female,Matched,2.733.333.333,,,,,,,,,,,,,,,,,,,,,85,,,,,,,,0,,,,,,,,,12/09/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,49e5ee61-a1c9-4038-84ac-92683e573a65,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,8,,OV,84,-31232,2.761.613.571,0:ALIVE OR DEAD TUMOR FREE,EUR,No,3.056,1.33,,2.761.613.571,0:CENSORED,,,No,,,,,23,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-24-1846-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,D1156Cfs*2,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41244082,41244083,-,ATCTAACA,17:g.41244082_41244083insATCTAACA,ENST00000357654.3:c.3458_3465dup,0.55,,95,79,,264,105,oct-23,,,,,,,,,9.838,,,,,,,SOC,4.372.554.821,0:LIVING,,,,,,1,,Primary,Female,Matched,3.566.666.667,,,,,,,,,,,,,,,,,,,,,45,,,,,,,,0,,,,,,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,67f526f1-def5-43b4-bc89-154baae190fc,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,10,-1,OV,133,-16534,4.372.554.821,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.941,2.34,,4.372.554.821,0:CENSORED,,,No,4,OV,,,24,Serous Cystadenocarcinoma,,0,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-29-1768-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,D295Tfs*3,Likely Oncogenic,NA,, NA,,NA,,Diploid,1,.,.,.,17,41246666,41246666,T,-,17:g.41246666del,ENST00000357654.3:c.882del,0.25,,55,164,,87,46,oct-23,,Pathogenic,,,,,,,3.906,,,,,,,SOC,3.129.828.714,1:DECEASED,,,White,,,1,,Primary,Female,Matched,1.533.333.333,,,,,,,,,,,,,,,,,,,,,50,,,,,,,,0,,,,,,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,838693d5-1ae0-4d75-834b-e1b89b96b0ed,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,7,,OV,950,-18396,3.129.828.714,1:DEAD WITH TUMOR,EUR,No,3.402,0.03,With Tumor,1.798.336.457,1:PROGRESSION,,,No,,,,,29,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-29-1776-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,R1188Efs*3,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41243985,41243986,CT,-,17:g.41243985_41243986del,ENST00000357654.3:c.3562_3563del,0.5,,91,91,,143,55,oct-23,,,,,,,,,4.367,,,,,,,SOC,1.183.548.673,0:LIVING,,,Black or African American,,,1,,Primary,Female,Matched,1.833.333.333,,,,,,,,,,,,,,,,,,,,,63,,,,,,,,0,,,,,,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,7472b3ba-9b15-4d97-8708-a2dd82ca0f45,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,7,-7,OV,360,-23016,1.183.548.673,0:ALIVE OR DEAD TUMOR FREE,AFR,Yes,2.815,1.6,With Tumor,1.183.548.673,0:CENSORED,,,No,-10,OV,,,29,Serous Cystadenocarcinoma,,-2,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-30-1857-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,K800*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,1,.,.,.,17,41245150,41245150,T,A,17:g.41245150T>A,ENST00000357654.3:c.2398A>T,0.58,,166,118,,288,103,oct-23,,,,,,,,Not Hispanic Or Latino,4.428,,,,,,,SOC,263.010.816,1:DECEASED,,,White,,,1,,Primary,Female,Matched,3.433.333.333,,,,,,,,,,,,,,,,,,,,,64,,,,,,,,0,,,,,,,,,06/02/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,45baebac-32ae-4093-9eba-488b95c1a58d,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,8,13,OV,8,-23689,263.010.816,1:DEAD WITH TUMOR,EUR,No,271,0.3,With Tumor,263.010.816,1:PROGRESSION,,,No,0,,,,30,Serous Cystadenocarcinoma,,14,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-36-2542-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,N1268Tfs*3,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,.,.,.,17,41243733,41243745,TTACTGCAGTCAT,-,17:g.41243733_41243745del,ENST00000357654.3:c.3803_3815del,0.48,,51,56,,265,73,oct-23,,,,,,,,Not Hispanic Or Latino,4.333,,,,,,,SOC,2.159.976.329,0:LIVING,,,Asian,,,1,,Primary,Female,Matched,2.5,,,,,,,,,,,,,,,,,,,,,59,,,,,,,,0,,,,2.159.976.329,0:DiseaseFree,,,,8/18/10,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,7aadc24b-3de2-478f-b9e5-aca44424f514,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,8,,OV,657,-21902,2.159.976.329,0:ALIVE OR DEAD TUMOR FREE,EAS,No,2.648,0.53,Tumor Free,2.159.976.329,0:CENSORED,,,No,,,,,36,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-36-2544-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,C328*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,.,.,.,17,41246566,41246567,AT,-,17:g.41246566_41246567del,ENST00000357654.3:c.981_982del,0.61,,99,62,,156,64,oct-23,,Pathogenic,,58,,,,,3.392,,,,,,,SOC,209.751.126,0:LIVING,,,,,,1,,Primary,Female,Matched,2.133.333.333,,,,,,,,,,,,,,,,,,,,,58,,,,,,,,0,,,,,,,,,8/18/10,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,da56dfbe-35ae-4bd7-9a11-d9bbb02b1833,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,3,,OV,638,-21384,209.751.126,0:ALIVE OR DEAD TUMOR FREE,EUR,No,296,1.76,With Tumor,1.068.481.441,1:PROGRESSION,,,No,,,,,36,Serous Cystadenocarcinoma,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)",TCGA-61-1914-01,Ovarian Epithelial Tumor,Serous Ovarian Cancer,L474*,Likely Oncogenic,NA,, NA,,NA,,Gain,1,.,.,.,17,41246127,41246127,A,C,17:g.41246127A>C,ENST00000357654.3:c.1421T>G,0.73,,159,58,,228,114,oct-23,,Pathogenic,,,,,,,4.098,,,,,,,SOC,5.661.307.821,0:LIVING,,,,,,1,,Primary,Female,Matched,3.766.666.667,,,,,,,,,,,,,,,,,,,,,65,,,,,,,,0,,,,5.503.501.332,1:Recurred/Progressed,,,,10/01/2009,,,No,,C56.9,8441/3,C56.9,Yes,,,,,,,,,,,,,8e1b8811-1eb2-4337-852c-c19eaa0ee418,,,,,,,,,,,,,,,,,,,,,,,,,,Ovary,,,9,23,OV,1722,-23850,5.661.307.821,0:ALIVE OR DEAD TUMOR FREE,EUR,Yes,2.599,0.61,With Tumor,5.503.501.332,1:PROGRESSION,,,No,8,OV,,,61,Serous Cystadenocarcinoma,,30,,,,,,,,,
"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)",SHAH_H001753_T04_01_WG01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R78Lfs*9,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Somatic,NA,.,17,41256952,41256955,TCTC,-,17:g.41256952_41256955del,ENST00000357654.3:c.231_234del,0.68,,42,20,,40,3,may-23,,,,,,,,,6.951,WGS,MSKCC,,,,,HGSOC,,,,Left Adnexa and Pelvic Peritoneum,,,Tumor,2,,Primary,,Matched,0.1,,HRD,HRD-Dup,Primary,HGS,,,,NO,58,SPECTRUM-OV-118,SHAH_H001753,S1,Primary Debulking,pre-Rx,Non-Adnexa,Other,Left Adnexa and Pelvic Peritoneum,Other,HRD-Dup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)",SHAH_H001753_T04_01_WG01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R78Sfs*10,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Somatic,NA,.,17,41256952,41256952,T,-,17:g.41256952del,ENST00000357654.3:c.234del,0.67,,44,22,,42,3,may-23,,,,,,,,,6.951,WGS,MSKCC,,,,,HGSOC,,,,Left Adnexa and Pelvic Peritoneum,,,Tumor,2,,Primary,,Matched,0.1,,HRD,HRD-Dup,Primary,HGS,,,,NO,58,SPECTRUM-OV-118,SHAH_H001753,S1,Primary Debulking,pre-Rx,Non-Adnexa,Other,Left Adnexa and Pelvic Peritoneum,Other,HRD-Dup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)",P-0061784-T01-IM7,Ovarian Cancer,High-Grade Serous Ovarian Cancer,T77Sfs*10,Likely Oncogenic,NA,, NA,,NA,,Diploid,,SOMATIC,Unknown,MSKCC,17,41256952,41256956,TCTCG,C,17:g.41256952_41256956delinsC,ENST00000357654.3:c.230_234delinsG,,,,,,,12,may-23,,,,,58,,NO,,5.462,IMPACT505,MSKCC,Anterior Abdominal Wall,MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.,3.26,Indeterminate,HGSOC,,,,Adnexa,,,Tumor,2,660,Metastasis,,Matched,9.844.166.839,70,HRD,HRD-Dup,Primary,HGS,,,,NO,58,SPECTRUM-OV-118,SHAH_H001753,S1,Laparoscopic Biopsy,pre-Rx,Non-Adnexa,Other,Anterior Abdominal Wall,Other,HRD-Dup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-24-1470-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,T1677Ifs*2,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,genome.wustl.edu,17,41219669,41219672,GTTA,-,17:g.41219669_41219672del,ENST00000357654.3:c.5030_5033del,,,,,,,61,16/23,,,,,,,,,4.107,,,,,,,HGSOC,3.42,0:LIVING,,,,,,1,,Primary,,Matched,2.033.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.42,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Tooearly,Complete Response,Yes,1-10 mm,IIIB,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-1494-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,X45_splice,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,broad.mit.edu,17,41258551,41258551,C,A,17:g.41258551C>A,ENST00000357654.3:c.135-1G>T,,,,,,,39,,,Pathogenic,,,,,,,4.586,,,,,,,HGSOC,38.14,0:LIVING,,,,,,1,,Primary,,Matched,1.366.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22.77,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-61-2109-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,K654Sfs*47,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,4,Germline,Valid,broad.mit.edu,17,41245587,41245587,T,-,17:g.41245587del,ENST00000357654.3:c.1961del,,,,,,,55,oct-23,,Pathogenic,,58,,,,,5.237,,,,,,,HGSOC,20.66,1:DECEASED,,,,,,1,,Primary,,Matched,1.866.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.28,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-1512-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,D825Efs*21,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,broad.mit.edu,17,41245073,41245073,G,-,17:g.41245073del,ENST00000357654.3:c.2475del,,,,,,,47,oct-23,,Pathogenic,,,,,,,7.095,,,,,,,HGSOC,03.09,0:LIVING,,,,,,1,,Primary,,Matched,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,03.09,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Tooearly,,Yes,No Macroscopic disease,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-25-2401-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,ShallowDel,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,52,19/23,,Pathogenic,,16,,,,,3.979,,,,,,,HGSOC,2.96,1:DECEASED,,,,,,1,,Primary,,Matched,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-1122-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,Amp,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,92,19/23,,Pathogenic,,16,,,,,6.166,,,,,,,HGSOC,39.06,1:DECEASED,,,,,,1,,Primary,,Matched,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14.69,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-09-2051-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,ShallowDel,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,83,19/23,,Pathogenic,,16,,,,,646,,,,,,,HGSOC,63.05,0:LIVING,,,,,,1,,Primary,,Matched,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19.15,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,No Macroscopic disease,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0883-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,ShallowDel,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,55,19/23,,Pathogenic,,16,,,,,5.361,,,,,,,HGSOC,68.86,1:DECEASED,,,,,,1,,Primary,,Matched,1.833.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.87,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-2077-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,ShallowDel,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,59,19/23,,Pathogenic,,16,,,,,651,,,,,,,HGSOC,115.81,0:LIVING,,,,,,1,,Primary,,Matched,2.033.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40.48,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,No Macroscopic disease,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-2081-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1756Pfs*74,Oncogenic,NA,, NA,,NA,,ShallowDel,1,Germline,Valid,broad.mit.edu,17,41209079,41209080,-,G,17:g.41209079_41209080insG,ENST00000357654.3:c.5266dup,,,,,,,38,19/23,,Pathogenic,,16,,,,,463,,,,,,,HGSOC,76.94,1:DECEASED,,,,,,1,,Primary,,Matched,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Progressive Disease,Yes,1-10 mm,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-1118-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,ShallowDel,2,Germline,Valid,genome.wustl.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,61,feb-23,,Pathogenic,,33,,,,,4.169,,,,,,,HGSOC,85.94,0:LIVING,,,,,,1,,Primary,,Matched,2.066.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.94,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-2078-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,ShallowDel,2,Germline,Valid,broad.mit.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,89,feb-23,,Pathogenic,,33,,,,,392,,,,,,,HGSOC,87.42,0:LIVING,,,,,,1,,Primary,,Matched,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.42,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,No Macroscopic disease,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-1027-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,Diploid,2,Germline,Valid,broad.mit.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,37,feb-23,,Pathogenic,,33,,,,,4.399,,,,,,,HGSOC,32.03,1:DECEASED,,,,,,1,,Primary,,Matched,1.266.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.75,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Resistant,Progressive Disease,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-23-2079-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,Diploid,2,Germline,Valid,broad.mit.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,43,feb-23,,Pathogenic,,33,,,,,5.075,,,,,,,HGSOC,91.6,0:LIVING,,,,,,1,,Primary,,Matched,1.466.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.3,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Resistant,Complete Response,Yes,No Macroscopic disease,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-10-0931-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,ShallowDel,2,Germline,Valid,broad.mit.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,27,feb-23,,Pathogenic,,33,,,,,397,,,,,,,HGSOC,32.85,1:DECEASED,,,,,,1,,Primary,,Matched,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.86,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Resistant,Complete Response,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-1408-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E23Vfs*17,Oncogenic,NA,, NA,,NA,,ShallowDel,2,Germline,NA,hgsc.bcm.edu,17,41276045,41276046,CT,-,17:g.41276045_41276046del,ENST00000357654.3:c.68_69del,,,,,,,77,feb-23,,Pathogenic,,33,,,,,6.201,,,,,,,HGSOC,5.91,0:LIVING,,,,,,1,,Primary,,Matched,2.666.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Partial Response,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-61-2008-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,W1815*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,broad.mit.edu,17,41199682,41199682,C,T,17:g.41199682C>T,ENST00000357654.3:c.5445G>A,,,,,,,46,22/23,,Pathogenic,,,,,,,6.941,,,,,,,HGSOC,30.59,0:LIVING,,,,,,1,,Primary,,Matched,1.566.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.84,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Complete Response,Yes,No Macroscopic disease,IIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-04-1356-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,N723Ifs*13,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,broad.mit.edu,17,41245382,41245382,G,-,17:g.41245382del,ENST00000357654.3:c.2166del,,,,,,,45,oct-23,,Pathogenic,,,,,,,7.459,,,,,,,HGSOC,49.25,1:DECEASED,,,,,,1,,Primary,,Matched,1.533.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.13,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Progressive Disease,Yes,,IIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-25-2392-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E1346Kfs*20,Likely Oncogenic,NA,, NA,,NA,,Diploid,,Germline,Valid,broad.mit.edu,17,41243513,41243513,T,-,17:g.41243513del,ENST00000357654.3:c.4035del,,,,,,,82,oct-23,,Pathogenic,,17,,,,,5.644,,,,,,,HGSOC,01.02,1:DECEASED,,,,,,1,,Primary,,Matched,2.766.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,,Yes,11-20 mm,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-09-1669-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E1346Kfs*20,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,hgsc.bcm.edu,17,41243513,41243513,T,-,17:g.41243513del,ENST00000357654.3:c.4035del,,,,,,,40,oct-23,,Pathogenic,,17,,,,,4.394,,,,,,,HGSOC,30.46,0:LIVING,,,,,,1,,Primary,,Matched,1.366.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,No Macroscopic disease,IIIA,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-09-2045-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1779Nfs*14,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,broad.mit.edu,17,41201209,41201209,G,-,17:g.41201209del,ENST00000357654.3:c.5335del,,,,,,,30,21/23,,Pathogenic,,,,,,,3.638,,,,,,,HGSOC,35.12,1:DECEASED,,,,,,1,,Primary,,Matched,1.033.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20.73,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Sensitive,Stable Disease,Yes,1-10 mm,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0893-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R504*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,genome.wustl.edu,17,41246039,41246040,-,TTTAATTTAT,17:g.41246039_41246040insTTTAATTTAT,ENST00000357654.3:c.1499_1508dup,,,,,,,59,oct-23,,Pathogenic,,,,,,,5.632,,,,,,,HGSOC,43.33,1:DECEASED,,,,,,1,,Primary,,Matched,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.15,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,Resistant,Partial Response,Yes,11-20 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-13-0903-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R504Vfs*28,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,genome.wustl.edu,17,41246038,41246038,G,-,17:g.41246038del,ENST00000357654.3:c.1510del,,,,,,,51,oct-23,,Pathogenic,,,,,,,389,,,,,,,HGSOC,47.34,0:LIVING,,,,,,1,,Primary,,Matched,1.766.666.667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,No Macroscopic disease,IV,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-24-2298-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,Q1395Lfs*11,Likely Oncogenic,NA,, NA,,NA,,Diploid,,Germline,Valid,broad.mit.edu,17,41242962,41242963,-,GA,17:g.41242962_41242963insGA,ENST00000357654.3:c.4182_4183dup,,,,,,,66,nov-23,,Pathogenic,,,,,,,5.763,,,,,,,HGSOC,53.22,1:DECEASED,,,,,,1,,Primary,,Matched,2.233.333.333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.41,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,>20mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-57-1582-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,R1726Kfs*3,Likely Oncogenic,NA,, NA,,NA,,Gain,,Germline,NA,hgsc.bcm.edu,17,41215363,41215366,TTTC,-,17:g.41215363_41215366del,ENST00000357654.3:c.5177_5180del,,,,,,,47,18/23,,Pathogenic,,58,,,,,6.123,,,,,,,HGSOC,24.02,1:DECEASED,,,,,,1,,Primary,,Matched,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1:Recurred/Progressed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Progressive Disease,Yes,1-10 mm,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)",TCGA-59-2348-01,Ovarian Cancer,High-Grade Serous Ovarian Cancer,E797*,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,NA,broad.mit.edu,17,41245159,41245159,C,A,17:g.41245159C>A,ENST00000357654.3:c.2389G>T,,,,,,,67,oct-23,,Pathogenic,,,,,,,5.551,,,,,,,HGSOC,180.04,0:LIVING,,,,,,1,,Primary,,Matched,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,180.04,0:DiseaseFree,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Yes,Yes,,Complete Response,Yes,,IIIC,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-13-0887-01,Ovarian Cancer,Serous Ovarian Cancer,C24Sfs*16,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,genome.wustl.edu,17,41276044,41276045,AC,-,17:g.41276044_41276045del,ENST00000357654.3:c.71_72del,,,,,,,81,feb-23,,,,,,,,NOT HISPANIC OR LATINO,6.669,,,,,,,SOC,66.62,1:DECEASED,,Bilateral,WHITE,,,1,,Primary,Female,Matched,2.733.333.333,,,,,,,,,,,,,,,,,,,,,42,,,Stage IIIC,,,,,0,,,,16.89,1:Recurred/Progressed,,,,2/25/09,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2002,NO,ASHKENAZI,80,1.3,,Tumor resection,,,,,,14c58def-60ee-48e0-a74b-da4eb77ef344,1713ce6c-f182-41df-a356-b073002ca1f7,TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf,AAEBFF3C-EA12-4D58-A424-2463307484A3,,,,Pre-Adjuvant Therapy,,,,,,,,1,0.4,,,1.2,,,,13,,WITH TUMOR,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)",TCGA-24-1470-01,Ovarian Cancer,Serous Ovarian Cancer,T1677Ifs*2,Likely Oncogenic,NA,, NA,,NA,,ShallowDel,,Germline,Valid,genome.wustl.edu,17,41219669,41219672,GTTA,-,17:g.41219669_41219672del,ENST00000357654.3:c.5030_5033del,,,,,,,61,16/23,,,,,,,,,4.107,,,,,,,SOC,3.45,0:LIVING,,Bilateral,WHITE,,,1,,Primary,Female,Matched,2.033.333.333,,,,,,,,,,,,,,,,,,,,,54,,,Stage IIIB,,,,,0,,,,3.45,0:DiseaseFree,,1,,05/12/2009,G3,Serous Cystadenocarcinoma,No,,C56.9,8441/3,C56.9,YES,2009,NO,,,1.2,,Tumor resection,,,,,,a3898640-0d85-441d-a000-b5b8ff857399,5287e961-91f0-4fb0-a00a-d570377cee62,TCGA-24-1470.f47eefcf-f15d-42cb-8bd2-d0c252ecafb3.pdf,f47eefcf-f15d-42cb-8bd2-d0c252ecafb3,,,,Other,,,,,,,,1,0.5,,,1,,,,24,,TUMOR FREE,Ovary,,A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)",P-0052359-T01-IM6,Ovarian Cancer,High-Grade Serous Ovarian Cancer,BRCA1 intragenic,Likely Oncogenic,NA,, NA,,NA,,Diploid,,SOMATIC,,N/A,17,41226412,,,,,,,,,,,,3,,,,,,68,,NO,,355,IMPACT468,MSKCC,Undesignated Tumor,,,,HGSOC,,,,Adnexa,,,Tumor,2,600,Metastasis,,Matched,2.594.094.285,40,HRD,HRD-Dup,NACT/IDS,HGS,,61,HRD,NO,68,SPECTRUM-OV-070,SHAH_H000181,S1,Laparoscopic Biopsy,pre-Rx,Non-Adnexa,Other,Undesignated Tumor,Other,HRD-Dup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)",P-0060931-T01-IM7,Ovarian Cancer,High-Grade Serous Ovarian Cancer,BRCA1-GPATCH8 Fusion,Likely Oncogenic,NA,, NA,,NA,,Diploid,,SOMATIC,,N/A,17,41256836,,,,,,,,,,,,10,,,,,,55,,NO,,5.064,IMPACT505,MSKCC,,MICROSATELLITE STABLE (MSS). See MSI note below.,2.4,Stable,HGSOC,,,,Right Ovary,,,Tumor,2,491,Primary,,Matched,8.203.472.366,50,HRD,HRD-Dup,Primary,HGS,,,,NO,54,SPECTRUM-OV-116,SHAH_H001750,S1,Primary Debulking,pre-Rx,Adnexa,Right Adnexa,Right Ovary,Adnexa,HRD-Dup,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"High-Grade Serous Ovarian Cancer (MSK, NPJ Genome Med 2021)",P-0015810-T01-IM6,Ovarian Cancer,High-Grade Serous Ovarian Cancer,S1370C,Unknown,medium,2.36, deleterious,0,benign,0.43,Diploid,,SOMATIC,Unknown,MSKCC,17,41243037,41243037,G,C,17:g.41243037G>C,ENST00000357654.3:c.4109C>G,0.33,,187,388,,563,10,nov-23,,,,,60,59,NO,Non-Spanish; Non-Hispanic,5.841,IMPACT468,MSKCC,,,2.21,Do not report,HGSOC,9.567,1:DECEASED,No,Pelvis,PT REFUSED TO ANSWER,NONE,Tumor,1,720,Primary,Female,Matched,864.698.095,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"High-Grade Serous Ovarian Cancer (MSK, NPJ Genome Med 2021)",P-0017175-T01-IM6,Ovarian Cancer,High-Grade Serous Ovarian Cancer,V1479M,Unknown,low,1.78, tolerated,0.06,benign,215,Diploid,,SOMATIC,Unknown,MSKCC,17,41228554,41228554,C,T,17:g.41228554C>T,ENST00000357654.3:c.4435G>A,0.2,9,151,607,1,1080,5,13/23,,Uncertain_significance,,,78,78,NO,Non-Spanish; Non-Hispanic,1.978,IMPACT468,MSKCC,Lymph Node,,0.66,Do not report,HGSOC,16.701,1:DECEASED,No,Ovary,ASIAN-FAR EAST/INDIAN SUBCONT,CATHOLIC/ROMAN,Tumor,1,707,Metastasis,Female,Matched,4.323.490.475,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,